Submit new post
Thank you for posting.
Share it:

6th Pharmacovigilance 2014

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"

04th & 05th March 2014, Thistle Marble Arch Hotel, London, UK
Contact: - Nisha: - +44 2079983304. Email –

• Joan Francesc Aregall Picamal, Pharmacovigilance Country Head, Bayer
• William Gregory, Director, Safety and Risk Management, Pfizer
• Christina Strom Moller, Vice President - Patient Safety Late Development & Marketed Products, AstraZeneca
• Arlene Gallagher, Statistician, Epidemiologist Clinical Practice Research Datalink, MHRA
• Ashish Kohli, Senior Director-Established Products Regulatory Portfolio Lead EU/Aus/NZ, Pfizer
• Julia Appelskog, Pharmacovigilance Country Lead, Merck
• Andrew Cochrane, Deputy EU QPPV, Novartis
• Sumit Munjal, Global Director, Pharmacovigilance & EU Region Medical Advisor - Lead Oncology Portfolio, Takeda Oncology: Millennium Pharmaceuticals
• Nicolas Limbos, Senior Drug Safety Scientist, Keyrus Biopharma
• Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)
• Steinar Madsen, Medical Director, Norweigen Medicines Agency
• David Jefferys, Sr. VP Regulatory, Eisai Pharmaceuticals
• Paul Dolin, Senior Director, Takeda Pharmaceuticals
• Pipasha Biswas, Director & QPPV, PV & Pharmacoepidemiology, Symogen
• John Talbot, Senior Lecturer, Pharmacovigilance, University of Hertfordshire
• Fiona Maini, Sr. Manager, Deloitte Consulting
• Joanna Hook, Associate, Bristows
Plus Many More...
Platinum Sponsor : - Dr. Ebeling & Assoc.Gmbh
Gold Sponsor : - Keyrus Biopharma
Gold Sponsor : - Advanced Drug and Device Services SAS
Bronze Sponsor : - Oviya MedSafe
Associate Sponsor : - Bytemindz
• Fiercest technologies, methodologies and introducing pharmacy automations on work practices of Pharmacovigilance in EU & US
• PRAC & European Pharmacovigilance legislation - Implementation and Beyond
• Updating yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
• How will PV activities change with Clinical trial transformation initiative?
• Pharmacovigilance system master file
• Audit and Inspection: Realistic steps for a fruitful consequence
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Impact of technology – learn and explore
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Determining the steps and strategies for enhancing quality in healthcare
• Signals: From detection to validation
• Review the use of Periodic Safety Update Reports (PSURs) post-authorisation for safety signals
• Legislative framework, including GVP modules
• Dwell ahead of regulatory developments & improving your risk management strategies in a cost effective way in EU, US
• Accelerating new medicine introduction in developing world & overcoming challenges
• Explaining how to use the data sources and observational research for effective safety analysis
• Be part of a major networking opportunity.

Introductory Offer (3 delegate places for the price of 2):- A huge saving of £1000 - (Limited seats left)
Super Early Discount (Till 20th December 2013):- Conference Delegate Pass (£ 500 + VAT per delegate)
Early Discount (21st December 2013 - 28th January 2014):- Conference Delegate Pass (£ 700 + VAT per delegate)
Standard Registration (29th January 2014):- Conference Delegate Pass (£ 1000 + VAT per delegate)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to-
Contact:-Nisha: - +44 2079983304. Email –